Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Safety and Immunogenicity of a Zoster Vaccine in SLE [Phase 4]
Phase 4 trial update on safety and immunogenicity of a zoster vaccine in patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus [Phase 2]
Phase 2 trial update for XmAb5871 in systemic lupus erythematosus has completed with results posted in 2019.
-
CLINICAL_TRIALS research · 2019-07-31Clinical Trial Update: An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults [Phase 2]
Open-label Phase 2 trial evaluating long-term safety of MEDI-546 for systemic lupus erythematosus (SLE) in adults.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) [Phase 4]
Phase 4 trial updates efficacy and safety of belimumab in Black patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2019-06-10Clinical Trial Update: Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus [Phase 2, Phase 3]
A clinical trial investigating ramipril's effects on endothelial function and endothelial progenitor cells in patients with systemic lupus e…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Rituximab Objective Outcome Measures Trial in SLE [Phase 2]
A Phase 2 clinical trial update on rituximab for systemic lupus erythematosus with arthritis is reported, but current status is unknown.
-
FDA approval · 2019-04-26FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for BENLYSTA (belimumab) from GlaxoSmithKline LLC.
-
FDA approval · 2019-04-26FDA Approved: BENLYSTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approves a supplemental application for Belimumab (Benlysta) submitted by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2019-04-26Clinical Trial Update: Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases [Phase 4]
Phase 4 trial evaluating an influenza A/H3N2 vaccine in patients with systemic lupus erythematosus and Sjogren's syndrome has completed.
-
FDA approval · 2019-04-23FDA Approved: AZATHIOPRINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for azathioprine from Zydus Lifesciences Limited.
-
FDA approval · 2019-04-23FDA Approved: AZATHIOPRINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for azathioprine from Rising Pharma Holdings, Inc., confirming a new generic form of the drug.
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 randomized, double-blind trial evaluated IPP-201101 plus standard of care vs placebo in systemic lupus erythematosus; study comple…
-
CLINICAL_TRIALS trial_result · 2019-04-11Clinical Trial Update: Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus [Phase 3]
A Phase 3 trial evaluating repeated administration of a 200-mcg dose of IPP-201101 plus standard of care in systemic lupus erythematosus has…
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Safety of IFNa Kinoid in Systemic Lupus Erythematosus [Phase 1, Phase 2]
Clinical trial update on the safety of IFNa Kinoid in systemic lupus erythematosus, completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) [Phase 2]
Phase 2 long-term follow-up study updates safety and tolerability of atacicept in systemic lupus erythematosus (SLE) after participation in …
-
CLINICAL_TRIALS trial_result · 2019-03-13Clinical Trial Update: Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. [Phase 2]
A Phase 2 trial evaluating the safety and tolerability of an intravenous dose of MEDI-546 in Japanese patients with systemic lupus erythemat…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 clinical trial update for ILT-101 in active moderate-to-severe systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Synergetic B-cell Immodulation in SLE [Phase 2]
Phase 2 trial update for a B-cell modulation approach in systemic lupus erythematosus.
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous [Phase 4]
Phase 4 clinical trial evaluating prophylactic trimethoprim/sulfamethoxazole to prevent severe infections in patients with systemic lupus er…
-
FDA approval · 2019-02-21FDA Approved: PREDNISONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for prednisone from Mylan Pharmaceuticals, indicating approval of an existing generic product's …
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus [NA]
This completed clinical trial investigates whether increased GADD34 gene expression has prognostic value for patients with systemic lupus er…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus [Phase 2]
Phase II study evaluating safety and efficacy of ALX-0061 in systemic lupus erythematosus has completed; results posted in 2019.
-
CLINICAL_TRIALS research · 2019-01-31Clinical Trial Update: Dissemination of the Lupus Interactive Navigator [NA]
The update reports completion and dissemination of the Lupus Interactive Navigator for Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE
This clinical trial update discusses evaluating the chemokine CXCL13 as a new diagnostic biomarker for systemic lupus erythematosus.
-
FDA approval · 2019-01-18FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic cyclophosphamide product. This marks approval of a generic formulation …